Secura Bio Holdings
San Diego, US · Founded 2018 · Delaware corporation
Founders & leadership
MS
Mark SpringNamed on SEC filing
BL
Brett LundNamed on SEC filing
JF
Jeffrey FerrellNamed on SEC filing
JL
Joseph LimberNamed on SEC filing
JE
Juan EstruchNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$105M disclosed across 1 round · 2019
▶$105MraisedMar 2019 · 14 investors · PharmaceuticalsRule 506(b)
▶$105MraisedMar 2019 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark SpringExecutive Officer
- Brett LundExecutive Officer
- Jeffrey FerrellDirector
- Joseph LimberExecutive Officer, Director
- Juan EstruchExecutive Officer
- Offering amount
- $145M
- Amount sold
- $105M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Secura Bio Holdings raised?
- Secura Bio Holdings has disclosed $105M raised across 1 round.
- Where is Secura Bio Holdings headquartered?
- Secura Bio Holdings is headquartered in San Diego, US.